April – June 2026Björn Thorngren, CEO, comments:"The second quarter was yet another step in MEDS' steady and long-term growth journey. Sales surpassed 300 MSEK (+17.6%) in a single quarter for the first time. At the same time, EBIT grew by as much as 38 percent. MEDS thus continues to grow while pr…
Paris, France – July 21, 2026Q2 2026 financial results and conference callViridien will publish its second quarter 2026 results on Thursday, July 30, after market close.Participants must register for the conference call by clicking here to receive a dial-in number and PIN code. Participants may als…
Net sales rose 8.5% at constant exchange rates, with strong growth across all regions and segments. Operating profit and net income were impacted by currency effects, but cash flow and equity remained robust. Sales acceleration in late Q2 signals improved profitability ahead.Original document: Swat…
Net profit rose 4.4% to CHF 63.6 million, with revenues up 2.6% and operating income up 2.9% year-over-year. Customer loans and assets under management both grew, while efficiency remained high with a 46.3% cost/income ratio.Original document: Walliser Kantonalbank [WKBN] Earnings Release — Jul. 21…
Total assets rose 3.4% to CHF 22.8 billion, with net profit up 4.4% to CHF 63.6 million year-over-year. Commission and trading income grew, while operating expenses remained controlled. No significant post-balance sheet events or changes in accounting principles.Original document: Walliser Kantonal…
Net income after Zakat rose 14.2% year-over-year to 13.8 billion, with strong growth in operating income, fee, and FX income. Corporate and SME financing expanded, while retail financing declined. Capitalization, liquidity, and asset quality remained robust.Original document: Al Rajhi Bank [1120] E…
Gross rental income grew 5.6% year-over-year, with strong leasing activity and high occupancy across all regions. Direct result per share remained stable, while new financing and asset rotation strengthened the balance sheet. FY 2026 guidance for direct result per share is reiterated at €1.85–1.95…
Q2 2026 saw 14% revenue and 55% EBITDA growth, driven by record messaging volumes and operational efficiency. Gross margin declined due to product mix, but adjusted EBITDA margin improved. Confident in achieving over 30% adjusted EBITDA growth for 2026.Original document: CM.com N.V. [CMCOM] Earning…
The merger will create Europe's largest independent oil and gas producer, combining high-quality assets and expanding access to European gas markets. Expected synergies of USD 250-300 million and increased dividend capacity support long-term value creation for shareholders.Original document: Var En…
Record net profit and EPS were achieved on the back of all-time high assets under management, strong client activity, and improved operating leverage. Capital and liquidity positions remain robust, with reaffirmed growth and efficiency targets for the coming years.Original document: Julius Baer Gru…
A merger will create Europe's largest independent oil and gas producer, combining high-quality assets and expanding market reach. BlueNord shareholders receive new shares and cash, with the deal expected to deliver significant synergies, increased dividends, and long-term value.Original document: B…
Net profit more than doubled year-over-year to CHF 519.4 million, driven by higher operating income and strong net commission and fee income. Assets under management rose to CHF 458.5 billion, supported by positive market performance and net inflows.Original document: Julius Baer Gruppe AG [BAER] I…
The combination will create Europe's largest independent oil and gas producer, targeting ~450 kboepd and delivering significant financial synergies, enhanced cash generation, and long-term dividend capacity. The deal is expected to close by end-2026, pending approvals.Original document: Var Energi…
A major combination with BlueNord will create Europe's largest independent oil and gas producer, raising long-term production targets and dividend capacity. The deal brings significant synergies, a robust resource base, and maintains strong financial discipline.Original document: Var Energi ASA [VA…
Organic sales grew 4.3% despite volume and currency headwinds, with EBIT margin at 11.2% and net income margin at 8.2%. Strong growth in North America and Rest of the World offset weaker Europe, while guidance for 2026 is reaffirmed at 4-6% organic growth.Original document: Chocoladefabriken Lindt…
Sales and EBITDA were stable year-over-year, with margin improvements and strong cash flow. Perlen Packaging saw robust demand and innovation, while Zeochem faced mixed results. The group raised its dividend payout ratio and expects slightly higher sales and EBITDA for 2026.Original document: CPH G…
Net sales for H1 2026 were CHF 2,332.1 million, with net income at CHF 191.7 million, both nearly flat year-over-year. A CHF 1 billion share buyback was launched, and a one-time U.S. tariff refund boosted other income. Seasonality continues to impact profitability and cash flow.Original document: C…
Organic sales grew 4.3% to CHF 2.33 billion, with strong double-digit growth in North America and Rest of the World, while Europe declined. EBIT margin improved to 11.2%, and free cash flow turned positive. Full-year guidance is confirmed, with targeted actions for volume recovery.Original document…
Q2 2026 saw 11% reported and 6% organic sales growth, with strong Prosthetics & Neuro Orthotics performance and improved EBITDA margin at 22%. Net profit rose 39% year-over-year, and free cash flow was robust. Guidance for 2026 organic sales growth narrowed to 5-7%.Original document: Embla Medical…
Net operating income and income from property management rose sharply year-over-year, driven by acquisitions, project completions, and higher rents. Occupancy reached 95%, and the property portfolio expanded to SEK 17,976 million. Robust liquidity and strong demand for logistics and light industria…
